VOR Vor Biopharma Inc.: institutional ownership and insider trading
111 funds reported holding $904M of Vor Biopharma Inc. in their latest 13F filings; in Q2 2026 funds net bought $146M, with 38 new positions and 17 funds selling out; over the last 12 months insiders bought $0 and sold $62.3M on the open market.
VOR revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$62.8M, EPS -1.16
- Quarter ended Mar 31, 2026: revenue n/a, net income −$220M, EPS -5.11
- Quarter ended Dec 31, 2025: revenue n/a, net income $1.72B, EPS 307.58
- Quarter ended Sep 30, 2025: revenue n/a, net income −$813M, EPS -121.63
Famous investors holding VOR
- Izzy Englander (Millennium Management): $7.88M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $2.95M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $1.01M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $681K, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $608K, 0.0% of the portfolio
Largest institutional holders of VOR
- TCG Crossover Management, LLC — $104M
- FMR LLC — $90.8M
- FCPM III SERVICES B.V. — $75.8M
- BlackRock, Inc. (BLK) — $63.8M
- VR Adviser, LLC — $56.0M
- STATE STREET CORP (STT, STT-PG) — $48.2M
- Frazier Life Sciences Management, L.P. — $46.8M
- RA CAPITAL MANAGEMENT, L.P. — $44.2M
- VANGUARD CAPITAL MANAGEMENT LLC — $38.4M
- Caligan Partners LP — $35.4M
Recent VOR insider trades
- Jul 16, 2026: RA Capital Healthcare Fund LP sold 213 shares ($4.21K)
- Apr 22, 2026: RA Capital Healthcare Fund LP sold 165,150 shares ($2.60M)
- Apr 20, 2026: RA Capital Healthcare Fund LP sold 630,374 shares ($10.2M)
- Apr 15, 2026: RA Capital Healthcare Fund LP sold 737,989 shares ($11.9M)
5%+ owners
- RA Capital Management, L.P.: 19.9% (Schedule 13D/A, filed Jul 21, 2026)
- FMR LLC: 12.0% (Schedule 13G/A, filed Aug 7, 2026)
- Chen Yu: 10.5% (Schedule 13G, filed Apr 1, 2026)
- Venrock Healthcare Capital Partners III, L.P.: 9.9% (Schedule 13G/A, filed Aug 14, 2026)
- Verve Capital Limited: 6.3% (Schedule 13G/A, filed Aug 13, 2026)
- BlackRock, Inc.: 5.7% (Schedule 13G, filed Jul 30, 2026)
Who owns the most VOR stock?
The largest institutional holders of Vor Biopharma Inc. in the latest 13F filings are TCG Crossover Management, LLC ($104M), FMR LLC ($90.8M), FCPM III SERVICES B.V. ($75.8M).
Are insiders buying or selling VOR?
Over the last 12 months insiders bought $0 and sold $62.3M of Vor Biopharma Inc. stock on the open market (SEC Form 4).
Which famous investors own VOR?
Izzy Englander, Ken Griffin, D. E. Shaw, Two Sigma, Renaissance Technologies.
Which ETFs hold VOR?
7 ETFs and mutual funds hold it among their top 100 positions, including FBIOX, FSCRX, FBTAX, FJACX.